Evofem Biosciences annual revenue
2019
2020
2021
2022
2023
2024
2025
Evofem Biosciences Revenue Growth & History (EVFM)
Evofem Biosciences reported $20.2M in revenue for fiscal 2025, an increase of 4.23% from the previous fiscal year.
View full Evofem Biosciences company overviewEvofem Biosciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $20.2M | $820,000 | +4.23% |
| 2024 | 2024-12-31 | $19.4M | $1.1M | +6.28% |
| 2023 | 2023-12-31 | $18.2M | $1.4M | +8.20% |
| 2022 | 2022-12-31 | $16.8M | $8.6M | +104.23% |
| 2021 | 2021-12-31 | $8.2M | $7.8M | +1748.43% |
| 2020 | 2020-12-31 | $446,000 | $446,000 | — |
| 2019 | 2019-12-31 | $0 | — | — |
Evofem Biosciences quarterly revenue
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.6M | −$2.2M | −45.43% |
| Q1 2026 | 2026-03-31 | $899,000 | $54,000 | +6.39% |
| Q4 2025 | 2025-12-31 | $9.6M | $2.5M | +34.59% |
| Q3 2025 | 2025-09-30 | $5.0M | $456,000 | +10.14% |
| Q2 2025 | 2025-06-30 | $4.8M | $665,000 | +15.99% |
| Q1 2025 | 2025-03-31 | $845,000 | −$2.8M | −76.55% |
| Q4 2024 | 2024-12-31 | $7.1M | $2.3M | +46.81% |
| Q3 2024 | 2024-09-30 | $4.5M | −$616,000 | −12.05% |
| Q2 2024 | 2024-06-30 | $4.2M | $1.7M | +69.24% |
| Q1 2024 | 2024-03-31 | $3.6M | −$2.2M | −37.98% |
| Q4 2023 | 2023-12-31 | $4.8M | $4.7M | +2573.48% |
| Q3 2023 | 2023-09-30 | $5.1M | −$1.3M | −19.76% |
| Q2 2023 | 2023-06-30 | $2.5M | −$3.6M | −59.26% |
| Q1 2023 | 2023-03-31 | $5.8M | $1.6M | +36.65% |
| Q4 2022 | 2022-12-31 | $181,000 | −$3.4M | −94.93% |
| Q3 2022 | 2022-09-30 | $6.4M | $4.7M | +272.14% |
| Q2 2022 | 2022-06-30 | $6.0M | $4.2M | +224.93% |
| Q1 2022 | 2022-03-31 | $4.3M | $3.1M | +284.71% |
| Q4 2021 | 2021-12-31 | $3.6M | $3.4M | +2025.00% |
| Q3 2021 | 2021-09-30 | $1.7M | $1.4M | +515.83% |
| Q2 2021 | 2021-06-30 | $1.9M | $1.9M | — |
| Q1 2021 | 2021-03-31 | $1.1M | $1.1M | — |
| Q4 2020 | 2020-12-31 | $168,000 | — | — |
| Q3 2020 | 2020-09-30 | $278,000 | $278,000 | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
| Q1 2020 | 2020-03-31 | $0 | — | — |
| Q3 2019 | 2019-09-30 | $0 | — | — |
Evofem Biosciences revenue growth trends
Over the last five reported fiscal years, revenue grew from $446,000 to $20.2M, a compound annual growth rate of 114.35%. Evofem Biosciences's latest reported quarter, Q2 2026, generated $2.6M in revenue, a decrease of 45.43% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Evofem Biosciences source filings ↗